Liquor Licensing Act 1997— Corporations and District Councils—Notices

Total Page:16

File Type:pdf, Size:1020Kb

Liquor Licensing Act 1997— Corporations and District Councils—Notices No. 81 4263 THE SOUTH AUSTRALIAN GOVERNMENT GAZETTE www.governmentgazette.sa.gov.au PUBLISHED BY AUTHORITY ALL PUBLIC ACTS appearing in this GAZETTE are to be considered official, and obeyed as such ADELAIDE, THURSDAY, 22 NOVEMBER 2007 CONTENTS Page Page Appointments, Resignations, Etc............................................. 4264 REGULATIONS Constitution Act 1934—Notice ............................................... 4264 Correctional Services Act 1982 (No. 259 of 2007).............. 4296 Controlled Substances Act 1984—REPUBLISHED ................... 4264 Liquor Licensing Act 1997— Corporations and District Councils—Notices.......................... 4334 (No. 260 of 2007)............................................................. 4298 Fisheries Act 1982—Notices................................................... 4264 (No. 261 of 2007)............................................................. 4300 Fruit and Plant Protection Act 1992—Notice .......................... 4265 Prevention of Cruelty to Animals Act 1985 Gaming Machines Act 1992—Notices .................................... 4265 (No. 262 of 2007)............................................................. 4302 Housing Improvement Act 1940—Notices.............................. 4266 Trade Measurement Act 1993 (No. 263 of 2007) ................ 4306 Liquor Licensing Act 1997—Notices...................................... 4270 Controlled Substances Act 1984— Local Government Act 1999—Notice..................................... 4274 (No. 264 of 2007)............................................................. 4308 Mining Act 1971—Notices...................................................... 4274 (No. 265 of 2007)............................................................. 4326 Motor Vehicles Act 1959—Notice.......................................... 4274 Security and Investigation Agents Act 1995 National Electricity Law—Notice ........................................... 4275 (No. 266 of 2007)............................................................. 4329 National Parks and Wildlife (National Parks) Correctional Services Act 1982 Regulations 2001—Notice................................................... 4275 (No. 267 of 2007)............................................................. 4331 Native Title (South Australia) Act 1994—Notice ................... 4274 Sale of Property....................................................................... 4335 Natural Resources Management Act 2004—Notice ................ 4276 Training and Skills Development Act 2003— Petroleum Act 2000—Notices................................................. 4276 Notice .................................................................................. 4284 Pharmacy Practice Act 2007—Notice ..................................... 4280 Treasury—Quarterly Statement............................................... 4285 Proclamations .......................................................................... 4294 Wilderness Protection Regulations 2006—Notice................... 4293 GOVERNMENT GAZETTE NOTICES ALL poundkeepers’ and private advertisements forwarded for publication in the South Australian Government Gazette must be PAID FOR PRIOR TO INSERTION; and all notices, from whatever source, should be legibly written on one side of the paper only and sent to Government Publishing SA so as to be received no later than 4 p.m. on the Tuesday preceding the day of publication. Phone 8207 1045 or Fax 8207 1040. E-mail: [email protected]. Send as attachments in Word format and please confirm your transmission with a faxed copy of your document, including the date the notice is to be published and to whom the notice will be charged. The Government Gazette is available online at: www.governmentgazette.sa.gov.au 4264 THE SOUTH AUSTRALIAN GOVERNMENT GAZETTE [22 November 2007 Department of the Premier and Cabinet CONSTITUTION ACT 1934 Adelaide, 22 November 2007 SECTION 13 (4) HIS Excellency the Governor in Executive Council has been Assembly to Fill Vacancy in Legislative Council pleased to appoint the undermentioned to the History Trust of South Australia, pursuant to the provisions of the History Trust of PURSUANT to a Proclamation made by His Excellency the South Australia Act 1981: Governor on 15 November 2007, an assembly of Members of both Houses of Parliament was held on 21 November 2007, to fill the Member: (from 22 November 2007 until 21 November 2010) seat in the Legislative Council which had become vacant by virtue Ian Short of the resignation of the Honourable Nicholas Xenophon, MLC. By command, At that Assembly, John Andrew Darley was duly elected to fill PAUL CAICA, for Premier the said vacancy. ASACAB006/02 J. M. DAVIS, Clerk of the Assembly of Members Department of the Premier and Cabinet Adelaide, 22 November 2007 FISHERIES ACT 1982: SECTION 59 HIS Excellency the Governor in Executive Council has been TAKE notice that pursuant to section 59 of the Fisheries Act pleased to appoint the Honourable Paul Holloway, MLC, Minister 1982, Jamieson P. Crawford, of Cleanseas Tuna Ltd, 7 North for Police, Minister for Mineral Resources Development and Quay Boulevard, Port Lincoln, S.A. 5606 (the ‘exemption holder’) Minister for Urban Development and Planning to be also Acting is exempt from the Fisheries Act 1982 and the Fisheries (General) Minister for Agriculture, Food and Fisheries and Acting Minister Regulations 2000, but only insofar as the exemption holder may for Forests for the period from 26 November 2007 until take up to six Yellowtail Kingfish (Seriola lalandi) using hook 6 December 2007 inclusive, during the absence of the Honourable and line method (hand or rod) for the purpose of aquaculture Rory John McEwen, MP. broodstock (the ‘exempted activity’), in the waters described in By command, Schedule 1, subject to the conditions set out in Schedule 2, from 15 November 2007 until 1 December 2007, unless varied or PAUL CAICA, for Premier revoked earlier. MAFF07/029CS SCHEDULE 1 Coastal waters adjacent to Coffin Bay (including Coffin Bay channel). [REPUBLISHED] SCHEDULE 2 IN Government Gazette No. 78 dated 8 November 2007, page 1. The specimens collected by the exemption holder must only 4168, sixth notice appearing on that page is replaced by this notice be used for aquaculture broodstock; all other species must be hereunder: released immediately. CONTROLLED SUBSTANCES ACT 1984 2. All specimens collected pursuant to this notice must not be sold or transferred to another party. Prohibition of Controlled Substances 3. All specimens collected pursuant to this exemption must not TAKE notice that on 2 November 2007, I, Keith Evans, Executive be held with any other captive specimens except with fish Director of Drug and Alcohol Services South Australia, having collected pursuant to another exemption issued for the purposes of formed the opinion that Cheryl Lynn Norton has administered a broodstock collection and may be held in ponds/tanks in the prescription drug in an irresponsible manner, exercise the Cleanseas Tuna Arno Bay hatchery, Licence No. FT00560 and/or authority delegated by the Minister for Mental Health and Cleanseas Tuna Port Augusta hatchery, Licence No. FT00287. Substance Abuse under section 62A of the Controlled Substances Act 1984, and make the following order under section 57 (1) of 4. The exemption holder must notify PIRSA Fisheries on 1800 the Act: 065 522 at least 12 hours prior to conducting the exempted activity and answer a series of questions about the exempted Cheryl Lynn Norton activity. The exemption holder will need to have a copy of the 73 Lacey Street exemption with them at the time of making the call, and be able to Whyalla, S.A. 5600 provide information about the area and time of the exempted is prohibited from supplying, administering or having possession activity, the vehicles and boats involved, the number of agents of any substances of the following class: undertaking the exempted activity and other related questions. Exemption No. 9902067. • A drug of dependence as declared by Regulation 7A of the Controlled Substances (Poisons) Regulations 1996, 5. The exemption holder must provide a written report to the pursuant to section 12 (3) of the Controlled Substances Act Director of Fisheries, (G.P.O. Box 1625, Adelaide, S.A. 5001) 1984, namely any poison listed in Schedule 8 of the within 14 days of any collection. The report is to provide details of Standard for the Uniform Scheduling of Drugs and Poisons the time, date, location and number of fish collected, including as published and amended by the National Drugs and details of any mortalities. Poisons Schedule Committee under the Commonwealth’s 6. The exemption holder shall also provide details of any Therapeutic Goods Act 1989. interactions with threatened, endangered and protected species. This order does not apply to any Drug of Dependence legally 7. The exemption holder shall record the number of wild supplied or prescribed for treatment of Cheryl Lynn Norton by a broodstock held pursuant to this notice in a register to be dentist or medical practitioner or by a veterinary surgeon for maintained at the registered aquaculture site, which must be made administration to an animal in her care. available for inspection by a PIRSA Fisheries Officer if requested. KEITH EVANS, Delegate for the Minister 8. The exemption holder must allow a Fisheries Officer or Controlled Substances Act another nominated person to be on board the boat during the exempted activity if requested by PIRSA Fisheries.
Recommended publications
  • (12) Patent Application Publication (10) Pub. No.: US 2006/0110428A1 De Juan Et Al
    US 200601 10428A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2006/0110428A1 de Juan et al. (43) Pub. Date: May 25, 2006 (54) METHODS AND DEVICES FOR THE Publication Classification TREATMENT OF OCULAR CONDITIONS (51) Int. Cl. (76) Inventors: Eugene de Juan, LaCanada, CA (US); A6F 2/00 (2006.01) Signe E. Varner, Los Angeles, CA (52) U.S. Cl. .............................................................. 424/427 (US); Laurie R. Lawin, New Brighton, MN (US) (57) ABSTRACT Correspondence Address: Featured is a method for instilling one or more bioactive SCOTT PRIBNOW agents into ocular tissue within an eye of a patient for the Kagan Binder, PLLC treatment of an ocular condition, the method comprising Suite 200 concurrently using at least two of the following bioactive 221 Main Street North agent delivery methods (A)-(C): Stillwater, MN 55082 (US) (A) implanting a Sustained release delivery device com (21) Appl. No.: 11/175,850 prising one or more bioactive agents in a posterior region of the eye so that it delivers the one or more (22) Filed: Jul. 5, 2005 bioactive agents into the vitreous humor of the eye; (B) instilling (e.g., injecting or implanting) one or more Related U.S. Application Data bioactive agents Subretinally; and (60) Provisional application No. 60/585,236, filed on Jul. (C) instilling (e.g., injecting or delivering by ocular ion 2, 2004. Provisional application No. 60/669,701, filed tophoresis) one or more bioactive agents into the Vit on Apr. 8, 2005. reous humor of the eye. Patent Application Publication May 25, 2006 Sheet 1 of 22 US 2006/0110428A1 R 2 2 C.6 Fig.
    [Show full text]
  • Texas Controlled Substances Act
    HEALTH AND SAFETY CODE TITLE 6. FOOD, DRUGS, ALCOHOL, AND HAZARDOUS SUBSTANCES SUBTITLE C. SUBSTANCE ABUSE REGULATION AND CRIMES CHAPTER 481. TEXAS CONTROLLED SUBSTANCES ACT SUBCHAPTER A. GENERAL PROVISIONS Sec.A481.001.AASHORT TITLE. This chapter may be cited as the Texas Controlled Substances Act. Acts 1989, 71st Leg., ch. 678, Sec. 1, eff. Sept. 1, 1989. Sec.A481.002.AADEFINITIONS. In this chapter: (1)AA"Administer" means to directly apply a controlled substance by injection, inhalation, ingestion, or other means to the body of a patient or research subject by: (A)AAa practitioner or an agent of the practitioner in the presence of the practitioner; or (B)AAthe patient or research subject at the direction and in the presence of a practitioner. (2)AA"Agent" means an authorized person who acts on behalf of or at the direction of a manufacturer, distributor, or dispenser. The term does not include a common or contract carrier, public warehouseman, or employee of a carrier or warehouseman acting in the usual and lawful course of employment. (3)AA"Commissioner" means the commissioner of state health services or the commissioner 's designee. (4)AA"Controlled premises" means: (A)AAa place where original or other records or documents required under this chapter are kept or are required to be kept; or (B)AAa place, including a factory, warehouse, other establishment, or conveyance, where a person registered under this chapter may lawfully hold, manufacture, distribute, dispense, administer, possess, or otherwise dispose of a controlled substance or other item governed by the federal Controlled Substances Act (21 U.S.C.
    [Show full text]
  • Prohibited Chemical Cn Ver4.00.Xlsx
    修订日:2021/7/15 Nitto集团 禁止含有的化学物质 Ver 4.00 分析 备注 物质 化学物质或物质群 阈值 数据 (记载的法律法规只用于对象物质的特定, 例举表 要否 其适用范围不作参考) (不使用保证书中收录的物质) EU REACH法规 AnnexⅩⅦ 未有意添加,且含量不超过1000ppm(不包 石棉类 需要 需要分析的仅限于滑石等可能有石棉混入的 表A 括1000ppm) 矿物原料 ― 部分偶氮染料/颜料(生成特定胺) 未有意添加 EU REACH法规 AnnexⅩⅦ 未有意添加,且镉含量不超过 镉及其化合物 需要 2011/65/EU(EU RoHS2指令) 5ppm(不包括5ppm) 未有意添加,且六价铬含量不超过 六价铬化合物 需要 2011/65/EU(EU RoHS2指令) 100ppm(不包括100ppm) 未有意添加,且铅含量不超过100ppm(不包 铅及其化合物 需要 2011/65/EU(EU RoHS2指令) 括100ppm) 未有意添加,且汞含量不超过100ppm(不包 汞及其化合物 需要 2011/65/EU(EU RoHS2指令) 括100ppm) 未有意添加,且PBB含量不超过100ppm(不 多溴联苯类(PBB类) 需要 2011/65/EU(EU RoHS2指令) 包括100ppm) 未有意添加,且PBDE含量不超过100ppm(不 2011/65/EU(EU RoHS2指令) 多溴联苯醚类(PBDE类) 需要 包括100ppm) 包括十溴联苯醚 蒙特利尔议定书 臭氧层破坏物质 未有意添加 ― 同时禁止在制造工序中使用 未有意添加,且含量不超过1000ppm(不包 邻苯二甲酸(2-乙基己基)酯(DEHP) 需要 2011/65/EU(EU RoHS2指令) 括1000ppm) 未有意添加,且含量不超过1000ppm(不包 邻苯二甲酸二正丁酯(DBP) 需要 2011/65/EU(EU RoHS2指令) 括1000ppm) 未有意添加,且含量不超过1000ppm(不包 邻苯二甲酸丁基苄酯(BBP) 需要 2011/65/EU(EU RoHS2指令) 括1000ppm) 未有意添加,且含量不超过1000ppm(不包 邻苯二甲酸二异丁酯(DIBP) 需要 2011/65/EU(EU RoHS2指令) 括1000ppm) 斯德哥爾摩公約 Annex A 多氯联苯类(PCB类) 未有意添加 ― 第一种特定化学物质(日本 化学物质的审 查及制造等的规制法)(以下简称化审法) 多氯三联苯类(PCT类) 未有意添加 ― EU REACH法规 AnnexⅩⅦ ― 多氯萘(氯原子数大于等于2) 未有意添加 化审法第一种特定化学物质 放射性物质 未有意添加 ― 使用放射性同位素的分析仪器除外 ― 斯德哥爾摩公約 Annex A 短链氯化石蜡(C10-C13) 未有意添加 化审法第一种特定化学物质 EU REACH法规 AnnexⅩⅦ 三丁基氧化锡(TBTO) 未有意添加 ― 化审法第一种特定化学物质 未有意添加,且含量不超过25ppb(不包括 全氟辛酸(PFOA)和其盐类及其PFOA的相关物 POPs公约 Annex A 25ppb)(PFOA相关物质不超过1000ppb) ― 质 EU POPs规则 附属书1 (不包括1000ppb) 未有意添加,且含量不超过25ppb(不包括 全氟乙基磺酸(PFHxS)及其盐类及PFHxS 相关 25ppb)(PFHxS相关物质不超过1000ppb) ― POPs公约 Annex A 物质 (不包括1000ppb) 三取代有机锡化合物 EU REACH法规 AnnexⅩⅦ 未有意添加 ― (包括TBT类、TPT类)(注1)
    [Show full text]
  • Comprehensive Multi-Analytical Screening Of
    COMPREHENSIVE MULTI-ANALYTICAL SCREENING OF DRUGS OF ABUSE, INCLUDING NEW PSYCHOACTIVE SUBSTANCES, IN URINE WITH BIOCHIP ARRAYS APPLIED TO THE EVIDENCE ANALYSER Darragh J., Keery L., Keenan R., Stevenson C., Norney G., Benchikh M.E., Rodríguez M.L., McConnell R. I., FitzGerald S.P. Randox Toxicology Ltd., Crumlin, United Kingdom e-mail: [email protected] Introduction Biochip array technology allows the simultaneous detection of multiple drugs from a single undivided sample, which This study summarises the analytical performance of three different biochip arrays applied to the screening of increases the screening capacity and the result output per sample. Polydrug consumption can be detected and by acetylfentanyl, AH-7921, amphetamine, barbiturates, benzodiazepines (including etizolam and clonazepam), incorporating new immunoassays on the biochip surface, this technology has the capacity to adapt to the new trends benzoylecgonine/cocaine, benzylpiperazines, buprenorphine, cannabinoids, carfentanil, dextromethorphan, fentanyl, in the drug market. furanylfentanyl, meprobamate, mescaline, methamphetamine, methadone, mitragynine, MT-45, naloxone, ocfentanyl, opioids, opiates, oxycodone, phencyclidine, phenylpiperazines, salvinorin, sufentanil, synthetic cannabinoids (JWH-018, UR-144, AB-PINACA, AB-CHMINACA), synthetic cathinones [mephedrone, methcathinone, alpha- pyrrolidinopentiophenone (alpha-PVP)], tramadol, tricyclic antidepressants, U-47700, W-19, zolpidem. Methodology Three different biochip arrays were used (DOA ULTRA,
    [Show full text]
  • List of Narcotic Substances Circulation of Which Is Restricted in Uzbekistan
    List of narcotic substances circulation of which is restricted in Uzbekistan 1. 2C-B(4-bromo-2,5-dimethoxyphenethylamine) 2. 3-methylfentanyl 3. 3-methylthiofentanyl 4. 3-Monoacetylmorphine 5. 4-methylaminorex 6. 6- Monoacetylmorphine 7. Acetorphine 8. Acetyl Dihydrocodeine 9. Acetyl-alfametilfentanil 10. Acetylated opium 11. Acetylcodeine 12. Acetylmethadol 13. Alfametadol 14. Alfatsetilmetadol 15. all fungi that contain Psilocine and Psilocybine 16. Allylprodine 17. Alpha Methylfentanyl 18. Alpha Metiltiofentanil 19. Alphaprodine 20. Anileridin 21. Benzethidine 22. Benzylmorphine 23. Betacetylmethadol 24. Betahydroxyfentanyl 25. Betameprodine 26. Betamethadol 27. Betaprodine 28. Bezitramide 29. Cannabis oil (hashish oil) 30. Cannabis, marihuana 31. Cathine ((+)-norpseudoephedrine) 32. Cathinone (l-alpha-aminopropiofenon) 33. Clonitazene 34. Cocaine 35. Codoxime 36. d- Methadone 37. DB [L-(3,4 - methylenedioxyphenyl) -2 butanamine] 38. Desmethylprodine; MPPP (1-methyl-4-phenyl-4-propionoxypiperidine) 39. Desomorphine 40. DET (N,N-diethyltryptamine) 41. Dexamphetamine 42. Diampromide 43. Diethyl phosphate 44. Diethylthiambutene 45. Dihydromorphine 46. Dimenoxadol 47. Dimepheptanol 48. Dimethylthiambutene 49. Dioxaphetyl butyrate 50. Diphenoxine 51. Dipipanone 52. DMA (2,5-dimethoxyamphetamine) 53. DMGP (dimetilgeptilpiran) 54. DMT (dimethyltryptamine) 55. DOB (d, L-2,5-dimethoxy-4-bromo-amphetamine) 56. DOC (d, L-2,5-dimethoxy-4-chloro-amphetamine) 57. DOET (2,5-dimethoxy-4-ethylamphetamine) 58. Drotebanol 59. Ecgonine 60. Ephedrone 61. Ethylmethylthiambutene 62. Eticyclidine 63. Etonitazene 64. Etorphine 65. Etoxeridine 66. Etryptamine 67. Furethidine 68. Hashish (Anasha, cannabis resin) 69. Heroin (Diacetylmorphine) 70. Hydrocodone 71. Hydrocodone phosphate 72. Hydromorphinol 73. Hydromorphone 74. Isomethadone 75. Ketobemidone 76. Khat 77. L- Methadone 78. Levomethorphan 79. Levomoramide 80. Levophenacylmorphan 81. Levorphanol 82. Lysergic acid and its preparations, that include d-Lysergide (LSD, LSD-25) 83.
    [Show full text]
  • Schedules of Controlled Substances (.Pdf)
    PURSUANT TO THE TEXAS CONTROLLED SUBSTANCES ACT, HEALTH AND SAFETY CODE, CHAPTER 481, THESE SCHEDULES SUPERCEDE PREVIOUS SCHEDULES AND CONTAIN THE MOST CURRENT VERSION OF THE SCHEDULES OF ALL CONTROLLED SUBSTANCES FROM THE PREVIOUS SCHEDULES AND MODIFICATIONS. This annual publication of the Texas Schedules of Controlled Substances was signed by John Hellerstedt, M.D., Commissioner of Health, and will take effect 21 days following publication of this notice in the Texas Register. Changes to the schedules are designated by an asterisk (*). Additional information can be obtained by contacting the Department of State Health Services, Drugs and Medical Devices Unit, P.O. Box 149347, Austin, Texas 78714-9347. The telephone number is (512) 834-6755 and the website address is http://www.dshs.texas.gov/dmd. SCHEDULES Nomenclature: Controlled substances listed in these schedules are included by whatever official, common, usual, chemical, or trade name they may be designated. SCHEDULE I Schedule I consists of: -Schedule I opiates The following opiates, including their isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, unless specifically excepted, if the existence of these isomers, esters, ethers, and salts are possible within the specific chemical designation: (1) Acetyl-α-methylfentanyl (N-[1-(1-methyl-2-phenethyl)-4-piperidinyl]-N- phenylacetamide); (2) Acetylmethadol; (3) Acetyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide); (4) Acryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacrylamide) (Other name:
    [Show full text]
  • Drug Early Warning from Re-Testing Biological Samples: Allen County, Indiana
    Drug Early Warning from Re-Testing Biological Samples: Allen County, Indiana Office of National Drug Control Policy Executive Office of the President July 2018 ACKNOWLEDGMENTS This report was funded by Cooperative Agreement #G1599ONDCP04A awarded by the Executive Office of the President, Office of National Drug Control Policy (ONDCP), to the University of Maryland’s Center for Substance Abuse Research (CESAR). Eric D. Wish, Ph.D. (Principal Investigator), Amy Billing, MSSA, and Eleanor Erin Artigiani, MA, produced this report. Fe Caces, Ph.D., served as reviewer and Project Manager at ONDCP and Terry Zobeck, Ph.D., also served as a reviewer. We are grateful to the criminal justice and laboratory staff that worked with us on this project. Without the support and assistance of the Allen County Adult Probation Program and the HOPE Probation staff, this project could not have been completed. The independent laboratory analyses for this report were conducted by the Armed Forces Medical Examiner System (AFMES) Laboratory. We would like to thank the specific staff listed below: Allen County Adult Probation (HOPE Probation - Indiana) Judge Wendy Davis Eric Zimmerman, Director of Court Services/Chief Probation Officer Steve Keele Thomas Felts Armed Forces Medical Examiner System, Division of Forensic Toxicology Dr. Jeff Walterscheid Lt. Commander Pedro Ortiz Major Lynn Wagner CTR Anastasia Berrier CTR Kimberley Heine CTR Theresa Hippolyte CTR Paul Kaiser ii Disclaimer The information and opinions expressed herein are the views of the authors and do not necessarily represent the views of the Office of National Drug Control Policy (ONDCP) of the Executive Office of the President, or any other agency of the Federal Government.
    [Show full text]
  • Medicines and Related Substances Act No. 101 of 1965
    MEDICINES AND RELATED SUBSTANCES ACT NO. 101 OF 1965 [View Regulation] [ASSENTED TO 19 JUNE, 1965] [DATE OF COMMENCEMENT: 1 APRIL, 1966] (Afrikaans text signed by the State President) This Act was published in Government Gazette 40869 dated 26 May, 2017. as amended by Drugs Control Amendment Act, No. 29 of 1968 Drugs Control Amendment Act, No. 88 of 1970 Drugs Laws Amendment Act, No. 95 of 1971 Drugs Control Amendment Act, No. 65 of 1974 Medicines and Related Substances Control Amendment Act, No. 19 of 1976 Health Laws Amendment Act, No. 36 of 1977 Medicines and Related Substances Control Amendment Act, No. 17 of 1979 Medicines and Related Substances Control Amendment Act, No. 20 of 1981 Transfer of Powers and Duties of the State President Act, No. 97 of 1986 [with effect from 3 October, 1986] Businesses Act, No. 71 of 1991 [with effect from 24 May, 1991] Medicines and Related Substances Control Amendment Act, No. 94 of 1991 General Law Amendment Act, No. 49 of 1996 [with effect from 4 October, 1996] Abolition of Restrictions on the Jurisdiction of Courts Act, No. 88 of 1996 [with effect from 22 November, 1996] Medicines and Related Substances Control Amendment Act, No. 90 of 1997 Medicines and Related Substances Amendment Act, No. 59 of 2002 Judicial Matters Amendment Act, No. 66 of 2008 [with effect from 17 February, 2009] Medicines and Related Substances Amendment Act No. 72 of 2008 Medicines and Related Substances Amendment Act, No. 14 of 2015 GENERAL NOTE There is a discrepancy between the English and Afrikaans texts of section 1 of Act No.
    [Show full text]
  • Descriptive, Observational Study of Pharmaceutical and Non-Pharmaceutical Arrests, Use, and Overdoses in Maine
    Open access Research BMJ Open: first published as 10.1136/bmjopen-2018-027117 on 29 April 2019. Downloaded from Descriptive, observational study of pharmaceutical and non-pharmaceutical arrests, use, and overdoses in Maine Kevin J Simpson,1 Matthew T Moran,1 Michelle L Foster,2 Dipam T Shah,1 Daniel Y Chung,1 Stephanie D Nichols,3 Kenneth L McCall,4 Brian J Piper1 To cite: Simpson KJ, Moran MT, ABSTRACT Strengths and limitations of this study Foster ML, et al. Descriptive, Objectives The Maine Diversion Alert Program grants observational study of healthcare providers access to law enforcement data on ► All arrests involving illicit or licit drugs reported to pharmaceutical and non- drug charges. The objectives of this report were to analyse pharmaceutical arrests, use, and the Diversion Alert Program of Maine in 2017 were variations in drug charges by demographics and examine overdoses in Maine. BMJ Open examined. recent trends in arrests, prescriptions of controlled 2019;9:e027117. doi:10.1136/ ► Controlled substance transactions reported to the substances and overdoses. bmjopen-2018-027117 Drug Enforcement Administration were evaluated. Design Observational. ► Drug-induced deaths (n=2432) reported to the ► Prepublication history and Setting Arrests, controlled prescription medication Maine Office of Medical Examiner were analysed. additional material for this distribution and overdoses in Maine. paper are available online. To ► These complementary results from Maine may not Participants Drug arrestees (n=1272) and decedents view these files, please visit generalise to larger states with younger or more di- (n=2432). the journal online (http:// dx. doi. verse populations. org/ 10. 1136/ bmjopen- 2018- Primary outcome measures Arrestees were analysed by 027117).
    [Show full text]
  • Prohibited Chemical E Ver4.00.Xlsx
    Revision date: July 15, 2021 Nitto Group Prohibited Chemical Substances or Substance Groups Version 4.00 Remarks Chemical Substance Analysis Threshold Level (Regulations used as a guide for identification of Examples or Substance Group Data substances, not for application purposes) Substances included on the list in Certificate for Non-Use of Prohibited Chemical Substances in Delivered Products EU REACH Annex XVII Asbestos No intentional addition and < 1000ppm Required Analysis required only for mineral raw materials that may Table A contain asbestos, such as talc Certain azo dyes/ pigments No intentional addition N/A EU REACH Annex XVII (producing specific amines) No intentional addition and < 5 ppm as Cadmium and cadmium compounds Required 2011/65/EU (EU RoHS2 Directive) cadmium No intentional addition and < 100 ppm as Hexavalent chromium compounds Required 2011/65/EU (EU RoHS2 Directive) hexavalent chromium No intentional addition and < 100 ppm as Lead and lead compounds Required 2011/65/EU (EU RoHS2 Directive) lead No intentional addition and < 100 ppm as Mercury and mercury compounds Required 2011/65/EU (EU RoHS2 Directive) mercury Polybrominated biphenyls No intentional addition and < 100 ppm as Required 2011/65/EU (EU RoHS2 Directive) (PBBs) PBB Polybrominated diphenyl ethers No intentional addition and < 100 ppm as Required 2011/65/EU (EU RoHS2 Directive) (PBDEs) PBDE Montreal Protocol Ozone depleting substances No intentional addition N/A Prohibiting use in manufacturing processes also Bis(2-ethylhexyl) phthalate No intentional
    [Show full text]
  • Chapter 152 Prohibited Drugs
    MINNESOTA STATUTES 1984 3593 PROHIBITED DRUGS 152.01 CHAPTER 152 PROHIBITED DRUGS 152.01 Definitions. 152.097 Simulated controlled substances. 152.02 Schedules of controlled substances; ad­ 152.10 Sales, persons eligible. ministration of chapter. 152.101 Manufacturers, records. 152.09 Prohibited acts. 152.11 Written or oral prescriptions, requisites. 152.092 Possession of drug paraphernalia pro­ 152.12 Doctors may prescribe. hibited. 152.13 Duties of state board of pharmacy. 152.093 Manufacture or delivery of drug para­ 152.15 Violations; penalties. phernalia prohibited. 152.151 Report to legislature. 152.094 Delivery of drug paraphernalia to a mi­ 152.18 Discharge and dismissal. nor prohibited. 152.19 Forfeitures. 152.095 Advertisement of drug paraphernalia 152.20 Penalties under other laws. prohibited. 152.205 Local regulations. 152.096 Conspiracies prohibited. 152.21 THC Therapeutic Research Act. 152.01 DEFINITIONS. Subdivision 1. Words, terms, and phrases. Unless the language or context clearly indicates that a different meaning is intended, the following words, terms, and phrases, for the purposes of this chapter, shall be given the meanings subjoined to them. Subd. 2. Drug. The term "drug" includes all medicines and preparations recognized in the United States pharmacopoeia or national formulary and any substance or mixture of substances intended to be used for the cure, mitigation, or prevention of disease of either man or other animals. Subd. 3. MS 1967 [Repealed, 1969 c 933 s 22] Subd. 3. Administer. "Administer" means to deliver by, or pursuant to the lawful order of a practitioner a single dose of a controlled substance to a patient or research subject by injection, inhalation, ingestion, or by any other immediate means.
    [Show full text]
  • Drugs and Medical Devices Group
    SCHEDULES OF CONTROLLED SUBSTANCES PURSUANT TO THE TEXAS CONTROLLED SUBSTANCES ACT, HEALTH AND SAFETY CODE, CHAPTER 481, THESE SCHEDULES, ESTABLISHED JANUARY 1, 2002, SUPERCEDE PREVIOUS SCHEDULES AND CONTAIN THE MOST CURRENT VERSION OF THE SCHEDULES OF ALL CONTROLLED SUBSTANCES FROM THE PREVIOUS SCHEDULES AND MODIFICATIONS. January 1, 2002 Changes to the schedules are designated by an asterisk (*). Additional information can be obtained by contacting the Texas Department of Health, Bureau of Food and Drug Safety, 1100 West 49th Street, Austin, Texas 78756. The telephone number is (512) 719-0237 and the website address is http://www.tdh.state.tx.us/bfds/dmd. SCHEDULES Nomenclature: Controlled substances listed in these schedules are included by whatever official, common, usual, chemical, or trade name they may be designated. SCHEDULE I Schedule I consists of: ! Schedule I opiates the following opiates, including their isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, unless specifically excepted, if the existence of these isomers, esters, ethers, and salts is possible within the specific chemical designation: (1) Acetyl-alpha-methylfentanyl (N-[1-(1-methyl-2-phenethyl)- 4-piperidinyl]- N- phenylacetamide); (2) Allylprodine; 1 (3) Alphacetylmethadol (except levo-alphacetylmethadol, also known as levo-alpha- acetylmethadol, levomethadyl acetate, or LAAM); (4) Alpha-methylfentanyl or any other derivative of Fentanyl; (5) Alpha-methylthiofentanyl (N-[1-methyl-2-(2-thienyl) ethyl-4-piperidinyl]-N- phenyl- propanamide);
    [Show full text]